Systems Biology in Biotech & Pharma: A Changing Paradigm (SpringerBriefs in Pharmaceutical Science & Drug Development)

Ales Prokop, Seth Michelson

ISBN 10: 9400728484 / ISBN 13: 9789400728486

Published by Springer 2012-01-05, 2012

About this Item

Seller Inventory # 6666-IUK-9789400728486

Bibliographic Details

• Title: Systems Biology in Biotech & Pharma: A Changing Paradigm (SpringerBriefs in Pharmaceutical Science & Drug Development)
• Publisher: Springer 2012-01-05
• Publication Date: 2012
• Language: English
• ISBN 10: 9400728484
• ISBN 13: 9789400728486
• Binding: Paperback
• Condition: New

About this title

Synopsis

The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts.

From the Back Cover

Systems Biology (SB) is a suite of technologies and methodologies that resulted, conceptually from the merging of two basic paradigms, reductionism and holism. It represents a combination of reductionist and holistic approaches to the relationships among the elements of a system, with the goal of identifying its emergent properties and defining, quantitatively, molecular, cellular, tissue, organ and whole body processes. One manifestation of SB is as a tool for hypothesis generation about a system that is typically too large and complex to understand by simple reasoning.